Potential for stem cell use in congenital heart disease

Future Cardiology

Volumn 8, Issue 2, 2012, Pages 161-169

  Pincott, Emma Siân ^a   Burch, Michael ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

cardiac tissue engineering; cell therapy; congenital heart disease; stem cell

Indexed keywords

ARTICLE; BIOENGINEERING; CARDIOMYOPLASTY; CONGENITAL HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TECHNOLOGY; TREATMENT INDICATION;

CHILD; CHILD WELFARE; CHILD, PRESCHOOL; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT WELFARE; INFANT, NEWBORN; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 84858660462     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.12.13     Document Type: Article

References (42)

1. Leri A, Kajstura J, Anversa P. Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ. Res. 109(8), 941-946 (2011
2. Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148 (2004 (Pubitemid 38891685)
3. Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ. Res. 96, 151-163 (2005 (Pubitemid 40209362)
4. Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv. Exp. Med. Biol. 686, 349-364 (2010
5. Vrtovec B, Poglajen G, Sever M. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J. Cardiac Fail. 17(4), 272-281 (2011
6. Arguero R, Careaga-Reyna G, Castano Guerra R. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report. Arch. Med. Res. 37, 1010-1014 (2006 (Pubitemid 44512065)
7. Strauer BE, Yousef M, Schannwell CM. The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heart failure: the STAR heart study. Eur. J. Heart Fail. 12, 721-729 (2010
8. Rupp S, Bauer J, Tonn T. Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old-child with dilated cardiomyopathy. Pediatr. Transplant. 13, 620-623 (2009
9. Rupp S, Zeiher AM, Dimmeler S et al. A regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells. J. Heart Lung Transplant. 29(5), 574-577 (2010
10. Pathak S, Lees C. Ultrasound structural fetal anomaly screening: an update. Arch. Dis. Child. Fetal Neonatal Ed. 94, F384-F390 (2009
11. Marek J, Tomek V, Škovránek J, Povýš ilová V, Šamánek M. Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21 year experience. Heart 97, 124-130 (2011
12. Shaw SW, Bollini S, Nader KA, Gastadello A et al. Autologous transplantation of amniotic fluid-derived mesenchymal stem cells into sheep fetuses. Cell Transplant. 20, 1015-1031 (2011
13. Wang F, Guan J. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Adv. Drug Deliv. Rev. 62, 784-797 (2010
14. Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 364, 183-192 (2004 (Pubitemid 38898735)
15. Menasché P, Alfieri O, Janssens S et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial. First randomized placebo-controlled study of myoblast transplantation. Circulation 117, 1189-1200 (2008
16. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K. Autologous stem cell transplantation in acute myocardial infarction: the ASTAMI randomized controlled trial. Intracoronary transplantation of autologos mononuclear bone marrow cells, study design and safety aspects. Scand. Cardiovasc. J. 39(3), 150-158 (2005 (Pubitemid 41657525)
17. Liras A. Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. J. Transl. Med. 8, 131 (2010
18. Rao M, Condic ML. Alternative sources of pluripotent stem cells: scientific solutions to an ethical dilemma. Stem Cells Dev. 17, 1-10 (2008 (Pubitemid 351271620)
19. Hyun I. The bioethics of stem cell research and therapy. J. Clin. Invest. 120, 71-75 (2010
20. Sandel MJ. Embryo ethics - the moral logic of stem-cell research. N. Eng. J. Med. 351(3), 207-209 (2004 (Pubitemid 38916036)
21. Jezierska-Wozniak K, Mystkowska D, Tutas A, Jurkowski MK. Stem cells as therapy for cardiac disease - a review. Folia Histochem. Cytobiol. 49(1), 13-25 (2011
22. Krane M, Werenet O, Wu SM. Promises and pitfalls in cell replacement therapy for heart failure. Drug Discov. Today Dis. Mech. 7 (2), e109-e115 (2010
23. Okita K, Nagata N, Yamanaka S. Immunogenicity of induced pluripotent stem cells. Circ. Res. 109, 720-721 (2011
24. Egashira T, Yuasa S, Fukuda K. Induced pluripotent stem cells in cardiovascular medicine. Stem Cells Int. 2011, 348960 (2011
25. Iyer RK, Chiu LLY, Reis LA, Radisic M. Engineered cardiac tissue. Curr. Opin. Biotechnol. 22(5), 706-714 (2011
26. Bollini S, Smart N, Riley PR. Resident cardiac progenitor cells: at the heart of regeneration. J. Mol. Cell. Cardiol. 50(2), 296-303 (2011
27. Smart N, Riley PR. The stem cell movement. Circ. Res. 102, 1155-1168 (2008
28. Weber B, Zeisberger SM, Hoerstrup SP. Prenatally harvested cells for cardiovascular tissue engineering: Fabrication of autologous implants prior to birth. Placenta 32(4), S316-S319 (2011
29. Planat-Bénard V, Menard C, André M et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ. Res. 94, 223-229 (2004 (Pubitemid 38197455)
30. Choi YS, Dusting GJ, Stubbs S et al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J. Cell. Mol. Med. 14(4), 878-889 (2010
31. Wu KH, Han ZC, Mo XM, Zhou B. Cell delivery in cardiac regenerative therapy. Ageing Res. Rev. 11(1), 32-40 (2011
32. Klein HM, Ghodsizad A, Marktanner R et al. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg. Forum 10(1), E66-E69 (2007
33. Boomsma RA, Swaminathan PD, Geenen DL. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Int. J. Cardiol. 122(1), 17-28 (2007 (Pubitemid 47503347)
34. Hare JM, Traverse JH, Henry TD et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54(24), 2277-2286 (2009
35. Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N. Engl. J. Med. 346(1), 5-15 (2002 (Pubitemid 34438914)
36. Dimmeler S, Vasa-Nicotera M. Aging of progenitor cells: limitation for regenerative capacity? J. Am. Coll. Cardiol. 42, 2081-2082 (2003 (Pubitemid 37549888)
37. Langer R, Vacanti JP. Tissue engineering. Science 260(5110), 920-926 (1993 (Pubitemid 23209960)
38. Wang C, Varshney RR, Wang D. Therapeutic cell delivery and fate control in hydrogels and hydrogel hybrids. Adv. Drug Deliv. Rev. 62(7-8), 699-710 (2010
39. Fujimoto KL, Ma Z, Nelson DM et al. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials 30, 4357-4368 (2009
40. Martinez EC, Kofidis T. Adult stem cells for cardiac tissue engineering. J. Mol. Cell. Cardiol. 50, 312-319 (2011
41. Davis DR, Smith RR, Marbán E. Stem cell technology: epigenetics, genomics, proteomics and metabonomics. Stem Cells 28, 903-904 (2010
42. Zakharova L, Mastroeni D, Mutlu N et al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc. Res. 87, 40-49 (2010)